Latest Breaking News On - Roger schibli - Page 1 : comparemela.com

New drug helps prostate cancer patients

New drug helps prostate cancer patients
labiotech.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labiotech.eu Daily Mail and Mail on Sunday newspapers.

Nicola acetoRoger schibliUniversity hospital baselPaul scherrer instituteCentre for radiopharmaceutical sciencesDamian wild of the university hospital baselDamian wildRadiopharmaceutical sciencesUniversity hospital

PSI-developed drug could increase survival chances for metastatic prostate cancer patients

Researchers at PSI have developed a new drug that could increase the survival chances of patients with metastatic prostate cancer.

Nicola acetoRoger schibliDanielle ellisCentre for radiopharmaceutical sciencesDamian wild of the university hospital baselUniversity hospital baselPaul scherrer institutePersonalised healthDamian wildRadiopharmaceutical sciencesUniversity hospitalProstate cancer

Molecular Partners to Present on its Radio DARPin Therapy

RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both.

United statesAlessandra villaSeth lewisStephan wullschlegerAnne goubierAlain blancAlexandra neculceaDaniel steinerStefan imoberstegAntonio ligiLiridon abduliChristian lizakPhilippe legenneJacqueline blunschiAndreas bosshartRoger schibli

ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer

ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Ben orzelekRoger schibliJulia hofmann svenjaSteffen schusterEuropean journal of nuclear medicineHead of the centerGroup leaderCorporate communicationsResearch group leaderPaul scherrer instituteTargeted radionuclide therapyScherrer instituteRadiopharmaceutical scienceRadionuclide therapyTechnologies munichEuropean journal

ITM Isotope Technologies Munich SE: ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer

Enhancement of ITM's development and manufacturing activities strengthens ITM's position as a pioneer and leader in Targeted Radionuclide Therapy (TRT) Garching / Munich, April 27, 2023 - ITM Isotope

Steffen schusterJulia hofmann svenjaBen orzelekRoger schibliGroup leaderResearch group leaderHead of the centerCorporate communicationsEuropean journal of nuclear medicinePaul scherrer instituteTargeted radionuclide therapyTechnologies munichRadiopharmaceutical scienceRadionuclide therapyEuropean journalNuclear medicine